Degree of control of cardiovascular risk factors in a group of patients with type 1 and 2 diabetes mellitus;Grado de control de factores de riesgo cardiovascular en una población de pacientes con diabetes mellitus tipo 1 y 2 de dificil manejo

Gaceta Medica de Mexico

Volumn 145, Issue 1, 2009, Pages 1-6

  López Maldonado, Francisco J ^a   Reza Albarrán, Alfredo A ^a   Suárez, Óscar J ^a   Villa, Antonio R ^a   Ríos Vaca, Aurelio ^a   Gómez Pérez, Francisco J ^a   Rull, Y Juan A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Cardiovascular risk; Diabetes mellitus; Dyslipidemia; High blood pressure

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIABETES CONTROL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; EVALUATION; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 67249144516     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dirección General de Información y Evaluación del Desempeño, Secretaría de Salud. Estadísticas de mortalidad en México: Muertes registradas en el año 2001. Salud Publica Mex 2003;44:565-576.
2. Stratton IM, Adler AI, Neil HA, et al. Association of glycemia and microvascular and microvascular complications in type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-412.
3. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713.
4. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393.
5. CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control and serum cholesterol level reduction for type 2 diabetes. JAMA 2002;287:2542-2551.
6. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
7. American Diabetes Association. Standards of medical care 2005. Diabetes Care 2005;28(suppl 1):S10.
8. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 2003;348:2294-2303.
9. Harris MI, Eastman RC, Cowie CC, et al. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999;22:403-408.
10. Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among US adults with diabetes, 1988-19994. Am J Prev Med 2002;22:42-48.
11. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-342.
12. Kemp TM, Barr ELM, ZimmetPZ, et al. Glucose, lipid and blood pressure control in australian adults with type 2 diabetes. Diabetes Care 2005;28:1490-1492.
13. Lepore G, Bruttomesso D, Nosari I, et al. Glycaemic control and microvascular complications in a large cohort of Italian type 1 diabetic out-patients. Diabetes Nutr Metab 2002;15:232-239.
14. Bruno G, Cavallo-Perin P, Bargero G, et al. Glycaemic control and cardiovascular risk factors in type 2 diabetes: A population-based study. Diabetes Med 1998;15:304-307.
15. Pena-Valdovinos A, Jiménez-Cruz A, Leyva-Pacheco R, Bacardi-Gascón M. Metabolism control in diabetic patients at the primary care level in México. Diabetes Res Clin Pract 1997;37:179-184.
16. Executive summary of the Third Report of the National Cholesterol Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
17. Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: Predicting risks by levels and ratios. Ann Intern Med 1994;121:641-617.
18. Ridker PM, Rafai N, Cook NR, et al. Non-HDL cholesterol, apolipoproteins A-I and apo B100, standard lipid measures, lipids ratios and CRP as risk factors for cardiovascular disease in women. JAMA 2005;294:326-333.